Waltham based Affinia Therapeutics raises $110M in Series B funding
Follow
Josh Lang
@BosBioJosh
Biotech enthusiast based in the epicenter of the industry, Kendall Square. One of the guys behind who likes sharing stories that excite him.
Josh Lang’s Tweets
Lexington based LogicBio Therapeutics announces strategic collaboration with Cambridge based CANbridge Pharmaceuticals Inc. LogicBio Therapeutics receives a payment of $10M upfront and additional milestone payments up to $581M alon…lnkd.in/dnVaKau
Mitsubishi Tanabe Pharma Corporation to open new research site in SmartLabs' Cambridge location
Boston based Monte Rosa Therapeutics raises $95M in Series C funding
1
Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts
Don't forget to sign up if you haven't already! We already have over 80 people signed up with over 200 expected with the event only 2 weeks away!
#networking #pharmaceuticals #bioxchange #drugdiscovery #biotechnetworking #drugdelivery #biotechnologyindu…
1
2
FDA fast-tracked more Massachusetts Institute of Technology-born biotechs than industry average, study finds
1
Chelmsford, MA has achieved the highest rating possible of Platinum status to announce their support to hosting and expanding the bio-tech industries in the community.
Boston based Valo raises $300M in Series B funding lnkd.in/drAuhyw
Cambridge based Moderna and Boston based Sherlock Biosciences both make the list
Cambridge based Takeda acquires Maverick Therapeutics for $525M
Cambridge based Quench Bio announces they are winding down operations
Boston based Ikena Oncology files for $100M
1
Waltham based Snapdragon Chemistry, Inc. is expanding and looks to double workforce
2
Cambridge based eGenesis, Inc. raises $125M in Series C funding
1
Cambridge based FogPharma raises $107M in Series C funding
Burlington based SalioGen Therapeutics comes out of stealth with $20M in Series A funding
Boston based TransCode Therapeutics, Inc. files for $30M IPO
Somerville based Finch Therapeutics Group files for $100M IPO
ALS Therapy Development Institute moves out of Kendall Square into new space in Watertown
Bristol Myers Squibb announces new state-of-the-art cell therapy manufacturing facility under construction in Devens
Cambridge based Beam Therapeutics acquires Guide Therapeutics for $120M
Cambridge Based LabCentral Announces $22.4 Million in Committed Funding for Shared Laboratory Space for Biotech Startups
Cambridge based Elicio Therapeutics raises $73M in Series B funding lnkd.in/dzNXCWq
1
Boston based ImmuneID launches with $17M
Cambridge based SHEPHERD Therapeutics and Brookline based Oncoheroes Biosciences announce partnership in the discovery, development, and commercialization of innovative drug products for rare oncology indications
1
Cambridge based Centessa Pharmaceuticals launches with $250M in Series A funding
1
Boston based Decibel Therapeutics raises $82M in IPO
Massachusetts Institute of Technology | edX has big plans for the site of the U.S. DOT Volpe National Transportation Systems Center in Kendall Square
Looking like there may be more lab space sprawling up around Boston. This time in Dorchester.
There is so much new lab space being built out around Boston, but is it too much or just enough to suit the demand
1
Woburn based CONTINUUS Pharmaceuticals is awarded $69.3M government contract as they look to bring drug manufacturing stateside. Company looks to hire more than 50 employee for new facility.
Waltham based TScan Therapeutics raises $100M in Series C funding
1
Registration is live for next week's . It will be hosted virtually on 's interactive networking platform on 12/16. tinyurl.com/y2zceehb #drugdiscovery #biotechnology #biotech #drugdevelopment #drugdelivery #lifesciences 100+ RSVPed currently
3
4
Registration is live for the next . It will be hosted virtually on 's interactive networking platform on 12/16. tinyurl.com/y2zceehb #drugdiscovery #biotechnology #biotech #drugdevelopment #drugdelivery #lifesciences
1
4
6
Cambridge based Biogen is adding two experimental candidates through collaboration with Sage Therapeutics where Sage receives $1.5B to start along with Biogen receiving a 10.7% stake in Sage Therapeutics.
1
Cambridge based Alnylam Pharmaceuticals gets FDA approval for drug for rare kidney disorder
The next is next week. It will be hosted virtually on 's interactive networking platform on 11/18. tinyurl.com/yydlevae #drugdiscovery #biotechnology #biotech #drugdevelopment #drugdelivery #lifesciences
2
5
After the #election, enter 2021 stronger than ever before with proactive steps for #lifesciences investment strategies with policy analysts. Join for discussion on the possible shift in the regulatory and policy environment. ow.ly/Y6lg50C1PRl #LSDealmaking20
1
1